| Literature DB >> 32042541 |
Shannon M Wood1, You J Kim1, Kevin C Chung1.
Abstract
Evidence-based medicine (EBM) is a triad that integrates the physician's medical expertise and the patient's individual characteristics with the best available scientific evidence. As patients become more active in the clinical decision-making process, the application of evidence-based practice in the field of plastic surgery is more critical now than ever. As a field that is recognized by its innovation, plastic surgeons must understand the various aspects of EBM to enhance and keep the field at the top of medical discovery. Many initiatives have been implemented to guide researchers in the collection, analysis, and distribution of high-quality evidence. In particular, Plastic and Reconstructive Surgery introduced a new EBM series to provide plastic surgeons with the appropriate resources to generate and integrate high-quality evidence into their practices. As a part of this initiative, this article will assist researchers in producing an evidence-based article that is well-written, relevant, and impactful to incorporate evidence-based practice into the specialty.Entities:
Year: 2019 PMID: 32042541 PMCID: PMC6964924 DOI: 10.1097/GOX.0000000000002544
Source DB: PubMed Journal: Plast Reconstr Surg Glob Open ISSN: 2169-7574
Fig. 1.The core principles of evidence-based medicine.
Fig. 2.Steps to writing an evidence-based medicine article.
Oxford’s Level of Evidence*
| Qualifying Studies | |
|---|---|
| Level 1 | |
| 1a | Systematic review of RCTs |
| 1b | Individual RCT (with >80% follow-up) |
| 1c | All or none (met when all patients died before the Rx became available, but some now survive on it; or when some patients died before the Rx became available, but none now die on it) |
| Level 2 | |
| 2a | Systematic review of cohort studies |
| 2b | Individual cohort study (including low quality RCT; eg, with <80% follow-up) |
| 2c | Outcomes research; ecological studies |
| Level 3 | |
| 3a | Systematic review of case-control studies |
| 3b | Individual case-control study |
| Level 4 | Case-series (and poor-quality cohort and case-control studies that failed to clearly define comparison groups and/or failed to measure exposures and outcomes in the same objective way in both control and experimental groups and/or failed to control for confounders) |
| Level 5 | Expert opinion without explicit critical appraisal, or based on physiology, bench research, or “first principles” |
*From the Centre for Evidence-Based Medicine. Oxford Centre for Evidence-Based Medicine, Available at https://www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/. Accessed June 3, 2019.
Grading of Recommendations, Assessment, Development, and Evaluations*
| Certainty | What It Means |
|---|---|
| High | The authors have a lot of confidence that the true effect is similar to the estimated effect |
| Moderate | The authors believe that the true effect is probably close to the estimated effect |
| Low | The true effect might be marked differently from the estimated effect |
| Very Low | The true effect is probably marked differently from the estimated effect |
*From the British Medical Journal Best Practices. What is GRADE? Available at https://bestpractice.bmj.com/info/us/toolkit/learn-ebm/what-is-grade/. Accessed July 10, 2019.
Addressing PICOS in an Evidence-based Medicine Article
| Questions to Consider | |
|---|---|
| Population/problem | Who is the cohort of patients? What is the specific condition being observed? |
| P | |
| Intervention | What is the intervention in question? |
| I | |
| Comparison | What is the control or comparison group? |
| C | |
| Outcomes | How is the effectiveness of the interventions being measured? |
| O | |
| Study design | What is the study design? |
| S |